Résumé
We report the antibiofilm activity by the sponge-associated bacterium Cobetia marina upon Staphylococcus epidermidis clinical isolates obtained from central venous catheters. Antibiofilm activity/antimicrobial susceptibility correlation might predict the action of the metabolite(s) upon Staphylococcus epidermidis in the clinic, making it a possible adjuvant in therapies against biofilm-associated infections.
Sujets)
Humains , Antibactériens/isolement et purification , Biofilms , Biotransformation , Prédisposition aux maladies , Pseudomonas aeruginosa/croissance et développement , Pseudomonas aeruginosa/isolement et purification , Infections à staphylocoques , Staphylococcus epidermidis/croissance et développement , Staphylococcus epidermidis/isolement et purification , Méthodes , Patients , Méthodes , VirulenceRésumé
We report the antibiofilm activity by the sponge-associated bacterium Cobetia marina upon Staphylococcus epidermidis clinical isolates obtained from central venous catheters. Antibiofilm activity/antimicrobial susceptibility correlation might predict the action of the metabolite(s) upon Staphylococcus epidermidis in the clinic, making it a possible adjuvant in therapies against biofilm-associated infections.